Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 811-824

  Pesakhov, Stella ^a   Khanin, Marina ^a   Studzinski, George P ^b   Danilenko, Michael ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSIC ACID; CASPASE 3; CASPASE 8; CASPASE 9; CURCUMIN; ENZYME INHIBITOR; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN MCL 1; SILIBININ;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL; MOLECULAR INTERACTION; OXIDATIVE STRESS;

APOPTOSIS; CASPASES; CELL PROLIFERATION; CURCUMIN; DITERPENES, ABIETANE; DRUG THERAPY, COMBINATION; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; OLIGOPEPTIDES; OXIDATIVE STRESS; PLANT EXTRACTS; SILYMARIN;

EID: 77954992253     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003693082     Document Type: Article

References (50)

1. Shipley JL, and Butera JN: Acute myelogenous leukemia. Exp Hematol 37, 649-658, 2009.
2. Fresco P, Borges F, Diniz C, and Marques MP: New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26, 747-766, 2006.
3. Anto RJ, Mukhopadhyay A, Denning K, and Aggarwal BB: Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23, 143-150, 2002.
4. Li M, Zhang Z, Hill DL, Wang H, and Zhang R: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67, 1988-1996, 2007.
5. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, and Aggarwal BB: Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 267, 133-164, 2008.
6. Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, et al.: Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 11, 6738-6744, 2005.
7. de Kok TM, van Breda SG, and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47 (Suppl 2), 51-59, 2008.
8. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP, et al.: The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int J Cancer 122, 1966-1971, 2008.
9. Khor TO, Keum YS, Lin W, Kim JH, Hu R, et al.: Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66, 613-621, 2006.
10. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, et al.: Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Res 67, 8274-8284, 2007.
11. RainaK, RajamanickamS, Singh RP, Deep G, Chittezhath M, et al.: Stage- specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 68, 6822-6830, 2008.
12. Singh RP, and Agarwal R: Prostate cancer chemoprevention by silibinin: bench to bedside. Mol Carcinog 45, 436-442, 2006. (Pubitemid 43865852)
13. Aruoma OI, Halliwell B, Aeschbach R, and Loligers J: Antioxidant and pro- oxidant properties of active rosemary constituents: Carnosol and carnosic acid. Xenobiotica 22, 257-268, 1992.
14. Mace K, Offord EA, Harris CC, and Pfeifer AM: Development of in vitro models for cellular and molecular studies in toxicology and chemoprevention. Arch Toxicol Suppl 20, 227-236, 1998.
15. Costa S, Utan A, Speroni E, Cervellati R, Piva G, et al.: Carnosic acid from rosemary extracts: a potential chemoprotective agent against aflatoxin B1. An in vitro study. J Appl Toxicol 27, 152-159, 2007.
16. Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y, et al.: Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1a,25- dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res 63, 1325-1332, 2003.
17. Danilenko M, Wang X, and Studzinski GP: Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst 93, 1224-1233, 2001.
18. Steiner M, Priel I, Giat J, Levy J, Sharoni Y, et al.: Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr Cancer 41, 135-144, 2001.
19. 3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol 204, 964-974, 2005.
20. Shabtay A, Sharabani H, Barvish Z, Kafka M, Amichay D, et al.: Synergistic antileukemic activity of carnosic acid-rich rosemary extract and 19-nor gemini vitamin D analog in a mouse model of systemic acute myeloid leukemia. Oncology 75, 203-214, 2008.
21. Sharabani H, Izumchenko E, Wang Q, Kreinin R, Steiner M, et al.: Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer 118, 3012-3021, 2006.
22. Polson RJ, Jenkins R, Lombard M, Williams AC, Roberts S, et al.: Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology 71, 176-181, 1990.
23. Deters M, Knochenwefel H, Lindhorst D, Koal T, Meyer HH, et al.: Different curcuminoids inhibit T-lymphocyte proliferation independently of their radical scavenging activities. PharmRes 25, 1822-1827, 2008.
24. Hayon T, Atlas L, Levy E, Dvilansky A, Shpilberg O, et al.: Multifactorial activities of nonsteroidal antiestrogens against leukemia. Cancer Detect Prev 27, 389-396, 2003.
25. Rozenszajn LA, Goldman I, Kalechman Y, Michlin H, Sredni B, et al.: T-lymphocyte colony growth in vitro: factors modulating clonal expansion. Immunol Rev 54, 157-186, 1981.
26. Meroni PL, Barcellini W, Borghi MO, Vismara A, Ferraro G, et al.: Sily- bin inhibition of human T-lymphocyte activation. Int J Tissue React 10, 177-181, 1988.
27. Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, et al.: Silymarin inhibits in vitro T cell proliferation and cytokine production in Hepatitis C virus infection. Gastroenterology 138, 671-681, 2010.
28. Min K, Yoon WK, Kim SK, and Kim BH: Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis. Arch Pharm Res 30, 1265-1272, 2007.
29. Hushmendy S, Jayakumar L, Hahn AB, Bhoiwala D, Bhoiwala DL, et al.: Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation. Nutr Res 29, 568-578, 2009.
30. Mainardi T, Kapoor S, and Bielory L: Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123, 283-294, 2009.
31. Crocenzi FA, and Roma MG: Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication. Curr Med Chem 13, 1055-1074, 2006.
32. Saller R, Brignoli R, Melzer J, and Meier R: An updated systematic review with meta-analysis for the clinical evidence of silymarin. Forsch Komplementmed 15, 9-20, 2008.
33. Woo JH, Kim YH, Choi YJ, Kim DG, Lee KS, et al.: Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis 24, 1199-1208, 2003.
34. Javvadi P, Segan AT, Tuttle SW, and Koumenis C: The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73, 1491-1501, 2008.
35. Fulda S, and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811, 2006.
36. Yin XM: Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10, 161-167,2000.
37. Zi X, and Agarwal R: Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl AcadSci USA 96, 7490-7495, 1999.
38. Mertens-Talcott SU, and Percival SS: Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218, 141-151, 2005.
39. Ghosh AK, Kay NE, Secreto CR, and Shanafelt TD: Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res 15, 1250-1258, 2009.
40. Wang Z, Desmoulin S, Banerjee S, Kong D, Li Y, et al.: Synergistic effects of multiple natural products in pancreatic cancer cells. Life Sci 83,293-300, 2008.
41. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, et al.: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7, 1166-1173, 2000.
42. Liao YF, Hung HC, Hour TC, Hsu PC, Kao MC, et al.: Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci 82, 367-375, 2008.
43. Wang R, Li H, Guo G, Li X, Yu X, et al.: Augmentation by carnosic acid of apoptosis in human leukaemia cells induced by arsenic trioxide via upregulation of the tumour suppressor PTEN. J Int Med Res 36, 682-690, 2008.
44. Park JA, Kim S, Lee SY, Kim CS, KimdoK, et al.: Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. Neuroreport 19, 1301-1304, 2008.
45. Rahman I, Biswas SK, and Kirkham PA: Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72, 1439-1452, 2006. (Pubitemid 44666744)
46. Jodoin J, Demeule M, and Beliveau R: Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 1542, 149-159, 2002.
47. Limtrakul P, Chearwae W, Shukla S, Phisalphong C, and Ambudkar SV: Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296, 85-95, 2007.
48. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, et al.: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895-2900, 2001.
49. Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, et al.: A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients. Invest New Drugs 25, 139-146, 2007.
50. Yan H, Wang L, Li X, Yu C, Zhang K, et al.: High-performance liquid chromatography method for determination of carnosic acid in rat plasma and its application to pharmacokinetic study. Biomed Chromatogr 23, 776-781, 2009.